摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

N-[(5-methyl-1H-imidazol-4-yl)methylidene]hydroxylamine | 112006-31-2

中文名称
——
中文别名
——
英文名称
N-[(5-methyl-1H-imidazol-4-yl)methylidene]hydroxylamine
英文别名
——
N-[(5-methyl-1H-imidazol-4-yl)methylidene]hydroxylamine化学式
CAS
112006-31-2
化学式
C5H7N3O
mdl
MFCD00465869
分子量
125.13
InChiKey
DRLHVAWTAGOTAU-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    384.8±30.0 °C(Predicted)
  • 密度:
    1.31±0.1 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    0.5
  • 重原子数:
    9
  • 可旋转键数:
    1
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.2
  • 拓扑面积:
    61.3
  • 氢给体数:
    2
  • 氢受体数:
    3

上下游信息

  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    N-[(5-methyl-1H-imidazol-4-yl)methylidene]hydroxylamine硝酸溶剂黄146 作用下, 反应 0.5h, 以30%的产率得到(1H)-4(5)-methylimidazole-4(5)-nitrolic acid
    参考文献:
    名称:
    Synthesis and Ocular Effects of Imidazole Nitrolic Acids
    摘要:
    Novel 1-R-imidazole-2-nitrolic acids and 1-R-imidazole-5-nitrolic acids (R: H, Me, Bn) were synthesized from oximes by treatment with a mixture of fuming nitric acid and acetic acid. The effects of these potential nitric oxide-donating compounds were tested on ocular variables such as intraocular pressure and formation of cyclic guanosine-3,5 '-monophosphate in the incubation of porcine iris-ciliary body.
    DOI:
    10.1021/jm048949+
  • 作为产物:
    参考文献:
    名称:
    Synthesis and Ocular Effects of Imidazole Nitrolic Acids
    摘要:
    Novel 1-R-imidazole-2-nitrolic acids and 1-R-imidazole-5-nitrolic acids (R: H, Me, Bn) were synthesized from oximes by treatment with a mixture of fuming nitric acid and acetic acid. The effects of these potential nitric oxide-donating compounds were tested on ocular variables such as intraocular pressure and formation of cyclic guanosine-3,5 '-monophosphate in the incubation of porcine iris-ciliary body.
    DOI:
    10.1021/jm048949+
点击查看最新优质反应信息

文献信息

  • INHIBITORS OF C-FMS KINASE
    申请人:Illig Carl R.
    公开号:US20070249649A1
    公开(公告)日:2007-10-25
    The invention is directed to compounds of Formula I: wherein Z, X, J, R 2 and W are set forth in the specification, as well as solvates, hydrates, tautomers and pharmaceutically acceptable salts thereof, that inhibit protein tyrosine kinases, especially c-fms kinase. Methods of treating autoimmune diseases; and diseases with an inflammatory component; treating metastasis from ovarian cancer, uterine cancer, breast cancer, colon cancer, stomach cancer, hairy cell leukemia and non-small lung carcinoma; and treating pain, including skeletal pain caused by tumor metastasis or osteoarthritis, or visceral, inflammatory, and neurogenic pain; as well as osteoporosis, Paget's disease, and other diseases in which bone resorption mediates morbidity including arthritis, prosthesis failure, osteolytic sarcoma, myeloma, and tumor metastasis to bone with the compounds of Formula I, are also provided.
    该发明涉及以下式I的化合物:其中Z、X、J、R2和W如规范中所述,以及其溶剂合物、合物、互变异构体和药用可接受的盐,这些化合物抑制蛋白酪氨酸激酶,特别是c-fms激酶。提供了治疗自身免疫疾病的方法;以及具有炎症成分的疾病;治疗卵巢癌、子宫癌、乳腺癌、结肠癌、胃癌、毛细胞白血病和非小细胞肺癌的转移;以及治疗疼痛,包括肿瘤转移或骨关节炎引起的骨骼疼痛,或内脏、炎症和神经源性疼痛;以及骨质疏松症、Paget病和其他骨吸收导致发病率的疾病,包括关节炎、假体失败、破骨性肉瘤、骨髓瘤和肿瘤转移至骨骼的方法,使用式I的化合物也提供了。
查看更多

同类化合物

相关结构分类